157 related articles for article (PubMed ID: 35121210)
41. Prior Direct Oral Anticoagulant Therapy is Related to Small Infarct Volume and No Major Artery Occlusion in Patients With Stroke and Non-Valvular Atrial Fibrillation.
Sakamoto Y; Okubo S; Sekine T; Nito C; Suda S; Matsumoto N; Nishiyama Y; Aoki J; Shimoyama T; Kanamaru T; Suzuki K; Mishina M; Kimura K
J Am Heart Assoc; 2018 Sep; 7(17):e009507. PubMed ID: 30371159
[TBL] [Abstract][Full Text] [Related]
42. Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
Toorop MMA; Chen Q; Tichelaar VYIG; Cannegieter SC; Lijfering WM
Eur Heart J; 2021 Oct; 42(40):4126-4137. PubMed ID: 34269375
[TBL] [Abstract][Full Text] [Related]
43. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
44. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation.
Seiffge DJ; Werring DJ; Paciaroni M; Dawson J; Warach S; Milling TJ; Engelter ST; Fischer U; Norrving B
Lancet Neurol; 2019 Jan; 18(1):117-126. PubMed ID: 30415934
[TBL] [Abstract][Full Text] [Related]
45. Anticoagulant Utilization and Direct Oral Anticoagulant Prescribing in Patients with Nonvalvular Atrial Fibrillation.
Shum P; Klammer G; Toews D; Barry A
Can J Hosp Pharm; 2019; 72(6):428-434. PubMed ID: 31853143
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the Safety and Effectiveness of Four Direct Oral Anticoagulants in Japanese Patients with Nonvalvular Atrial Fibrillation Using Real-World Data.
Enomoto A; Mano Y; Kawano Y; Nishikawa T; Aoyama T; Sasaki Y; Nagata M; Takahashi H
Biol Pharm Bull; 2021; 44(9):1294-1302. PubMed ID: 34471057
[TBL] [Abstract][Full Text] [Related]
47. Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry.
Murata N; Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itoh S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
Circ J; 2019 Mar; 83(4):727-735. PubMed ID: 30726797
[TBL] [Abstract][Full Text] [Related]
48. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study.
Anguita Sánchez M; Bertomeu Martínez V; Ruiz Ortiz M; Cequier Fillat Á; Roldán Rabadán I; Muñiz García J; Badimón Maestro L; Esteve Pastor MA; Marín Ortuño F;
Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):14-20. PubMed ID: 31160265
[TBL] [Abstract][Full Text] [Related]
49. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment.
Ting C; Rhoten M; Dempsey J; Nichols H; Fanikos J; Ruff CT
Clin Appl Thromb Hemost; 2021; 27():1076029620987900. PubMed ID: 33517715
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.
Russo V; Cattaneo D; Giannetti L; Bottino R; Laezza N; Atripaldi U; Clementi E
Clin Ther; 2021 Sep; 43(9):e255-e263. PubMed ID: 34366151
[TBL] [Abstract][Full Text] [Related]
52. Real-world persistence with direct oral anticoagulants (DOACs) in naïve patients with non-valvular atrial fibrillation.
Ferroni E; Gennaro N; Costa G; Fedeli U; Denas G; Pengo V; Corti MC
Int J Cardiol; 2019 Aug; 288():72-75. PubMed ID: 31043323
[TBL] [Abstract][Full Text] [Related]
53. A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras.
Brown JD; Shewale AR; Dherange P; Talbert JC
Drugs Aging; 2016 Jun; 33(6):427-36. PubMed ID: 27154397
[TBL] [Abstract][Full Text] [Related]
54. Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
Deguchi I; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2627-2631. PubMed ID: 29970321
[TBL] [Abstract][Full Text] [Related]
55. Ischemic stroke and systemic embolism among patients with non-valvular atrial fibrillation who abandon oral anticoagulant therapy.
Alberts MJ; Zhdanava M; Pilon D; Caron-Lapointe G; Lefebvre P; Bookhart B; Kharat A
Curr Med Res Opin; 2023 Sep; 39(9):1279-1286. PubMed ID: 37589313
[TBL] [Abstract][Full Text] [Related]
56. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
[TBL] [Abstract][Full Text] [Related]
57. Anticoagulant prescribing in patients with ischaemic stroke: what has changed over a decade?
Sharobeam A; Jones B; Watters A; Das C; Lueck C
Intern Med J; 2020 Oct; 50(10):1274-1277. PubMed ID: 33111414
[TBL] [Abstract][Full Text] [Related]
58. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
[TBL] [Abstract][Full Text] [Related]
59. The Impact of Body Weight and Renal Function on the Risk of Bleeding With Direct Oral Anticoagulants in Atrial Fibrillation.
Whittemore H; Posen AK; Hellenbart EL; Groo V; Wenzler E; Tilton JJ
Ann Pharmacother; 2021 Nov; 55(11):1309-1317. PubMed ID: 33601914
[TBL] [Abstract][Full Text] [Related]
60. Effectiveness and Safety of Direct Oral Anticoagulants in the Secondary Stroke Prevention of Elderly Patients: Ljubljana Registry of Secondary Stroke Prevention.
Frol S; Sernec LP; Hudnik LK; Šabovič M; Oblak JP
Clin Drug Investig; 2020 Nov; 40(11):1053-1061. PubMed ID: 32886321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
